Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Common Equity (2016 - 2025)

Medicure has reported Common Equity over the past 17 years, most recently at $9.3 million for Q4 2025.

  • For Q4 2025, Common Equity fell 37.76% year-over-year to $9.3 million; the TTM value through Dec 2025 reached $9.3 million, down 37.76%, while the annual FY2025 figure was $9.3 million, 37.76% down from the prior year.
  • Common Equity for Q4 2025 was $9.3 million at Medicure, down from $12.6 million in the prior quarter.
  • Over five years, Common Equity peaked at $16.3 million in Q3 2023 and troughed at $9.3 million in Q4 2025.
  • A 5-year average of $14.3 million and a median of $14.6 million in 2021 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: grew 18.66% in 2022 and later plummeted 37.76% in 2025.
  • Year by year, Common Equity stood at $14.6 million in 2021, then grew by 5.95% to $15.5 million in 2022, then fell by 5.56% to $14.6 million in 2023, then grew by 1.78% to $14.9 million in 2024, then plummeted by 37.76% to $9.3 million in 2025.
  • Business Quant data shows Common Equity for MCUJF at $9.3 million in Q4 2025, $12.6 million in Q3 2025, and $13.2 million in Q2 2025.